Benedetto Bruno
机构: Department of Molecular Biotecnology and Health Sciences
每年引用次数
引用次数
引用: 16,242
H-指数: 68
I10-指数 : 204
出版物: 713
Hematopoietic Cell Transplants (HCT) from HLA-Matched Related (MRD) and Unrelated (URD) Donors for Patients with Hematologic Malignancies Using Low-Dose TBI Conditioning.
Brenda M. Sandmaier , D.W. Niederwieser , W. Bethge , M. Pulsipher
Blood 106 ( 11) 655 -655
4
2005
ASCT as consolidation therapy acute myeloid leukemia
A. Olivieri , I. Attolico , B. Bruno
Haematologica 94
2009
SAFETY AND EFFICACY OF BORTEZOMIB IN RELAPSED MULTIPLE MYELOMA FOLLOWING REDUCED INTENSITY/NONMYELOABLATIVE CONDITIONINGS AND ALLOGENEIC HAEMATOPOIETIC CELL TRANSPLANTATION
R. Sorasio , J. Peccatori , V. Montefusco , G. Milone
Haematologica 0308 -0308
2006
NONMYELOABLATIVE ALLOGRAFTING OR AUTOGRAFTING FOR NEWLY DIAGNOSED MULTIPLE MYELOMA
R. Sorasio , S. Bringhen , M. Massaia , G. Ciccone
Haematologica
2007
INCIDENCE OF INVASIVE ASPERGILLOSIS IN ALLOGENEIC STEM CELL TRANSPLANTATION RECIPIENTS: AN ITALIAN PROSPECTIVE MULTICENTER STUDY
R. Sorasio , M. Boccadoro , B. Allione , D. Mattei
Haematologica 0209 -0209
2007
HLA disparities on unshared haplotype influence outcomes of unmanipulated haploidentical hematopoietic stem cell transplantation (HaploSCT): A Study from the Acute Leukemia Working Party of European Society for Blood and Marrow Transplantation (EBMT)
A. Ruggeri , W. Arcese , D. Blaise , K. Fleischhauer
Bone Marrow Transplantation
2016
Impact of Conditioning Regimen on Outcomes of T-Replete Haplo-Identical Transplantation for Patients Over 45 Years-Old with AML: A Study On Behalf Of the Acute Leukemia Working Party of the EBMT
S. Santarone , B. N. Savani , M. Labopin , J. Tischer
Haematologica
2017
Risk of hepatitis B and efficacy of treatment with lamivudine in patients undergoing allo-SCT
L. Mezzabotta , L. Giaccone , I. Resta , A. Marengo
Digestive and Liver Disease 40 ( 5)
2008
Treatment for acute myelogenous leukemia by low dose Total Body Irradiation (TBI) based conditioning and hematopoietic cell transplantation from related and unrelated donors
G.N. Franke , U. Hegenbart , D. Niederwieser , B.M. Sandmaier
Biology of Blood and Marrow Transplantation 12 ( 2) 31 -32
7
2006
Unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with poor risk, relapsed or refractory multiple myeloma
G.E. Georges , M.B. Maris , B.M. Sandmaier , M.J. Stuart
Biology of Blood and Marrow Transplantation 10 72
2004
TID compared to BID mycophenolate mofetil (MMF) improves donor chimerism and engraftment rates without increasing postgrafting toxicities after unrelated peripheral blood stem cell (PBSC) transplantation (HCT) with nonmyeloablative conditioning
M.B. Maris , B.M. Sandmaier , B. Storer , M. Stuart
Biology of Blood and Marrow Transplantation 10 35 -36
2004
Treatment of patients (pts) with chemotherapy-refractory chronic lymphocytic leukemia (CLL) with nonmyeloablative (NM) conditioning and hematopoietic cell transplantation (HCT) from HLA-matched related (MRD) or unrelated donors (URD)
M.L. Sorror , M.B. Maris , B.M. Sandmaier , M. Jain-Stuart
Biology of Blood and Marrow Transplantation 10 26 -26
5
2004
Allogeneic Hematopoietic Cell Transplantation (HCT) with Nonmyeloablative Conditioning after Failed Myeloablative HCT: Factors Affecting Outcomes.
Frederic Baron , R. Storb , B. Storer , D. Maloney
Blood 106 ( 11) 1143 -1143
1
2005
EARLY RESULTS OF A PHASE II STUDY ADDING PERI-TRANSPLANT RITUXIMAB TO NONMYELOABLATIVE CONDITIONING AND ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION (HCT) FOR PATIENTS (PTS) WITH HIGH-RISK FLUDARABINE-REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
M.L. Sorror , B. Storer , B.M. Sandmaier , T. Chauncey
Biology of Blood and Marrow Transplantation 18 ( 2)
2012
A Randomized Phase III Trial Investigating 2 Gy TBI Vs. Flu/2 Gy TBI Conditioning for HLA-Matched Related Donor Hematopoietic Cell Transplantation (HCT): Tempo of CD3 and NK Cell Engraftment Determines Relapse and Progression Free Survival in Patients with Hematologic
B. Kornblit , B. Storer , R.F. Storb , P. Hari
Biology of Blood and Marrow Transplantation 18 ( 2)
2012
An update of a comparison of nonmyeloablative allografting with autografting for newly diagnosed myeloma.
B. Bruno , R. Sorasio , F. Patriarca , N. Mordini
Blood 110 ( 11) 482 -482
2007
Disease and Comorbidity Status Predict Outcome after Nonmyeloablative Allografting for Advanced Haematological Malignancies.
A. Bosi , Mario Boccadoro , B. Bruno , R. Sorasio
Blood 110 ( 11) 4930 -4930
2007
Trichoderma species fungemia after high-dose chemotherapy and autologous stem cell transplantation: a case report
M. Festuccia , L. Giaccone , F. Gay , L. Brunello
Transplant Infectious Disease 16 ( 4) 653 -657
4
2014
Long Term Follow-Up of a Donor Versus no Donor Comparison in Multiple Myeloma Patients at First Relapse After Previous Autotransplant
F. Patriarca , H. Einsele , F. Spina , B. Bruno
Clinical Lymphoma, Myeloma & Leukemia 15
2015
European Myeloma Network recommendations on the evaluation and treatment of newly diagnosed patients with multiple myeloma
M. Engelhardt , E. Terpos , M. Kleber , F. Gay
Haematologica 99 ( 2) 232 -242
257
2014